Merck & Co., Inc. (MRK)
TSX
Closed
Aug 25, 2026
Day's Range
34.0052 wk Range
17.66Overview - MRK - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
571.86B
P/E (Trailing)
‪124.50‬
PEG Ratio
‪-0.95‬
Price / Sales (TTM)
‪8.26‬
Price / Book
‪12.68‬
EV / EBITDA
‪19.64‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪74.80%‬
Operating Margin
‪34.49%‬
Return on Assets
‪13.33%‬
Return on Equity
‪34.66%‬
Ownership
Shares Outstanding
2.46B
Price stats
50-Day Avg
‪28.70‬
200-Day Avg
‪26.93‬
Dividends
Frequency
Quarterly
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MRK - Merck & Co., Inc.
Peers - MRK - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on TSX.
Profile Summary - MRK - Merck & Co., Inc.
About
Merck & Co., Inc. is a leading global healthcare company specializing in the discovery, development, manufacturing, and marketing of prescription medicines, vaccines, biologic therapies, and animal health products. Its pharmaceutical segment features blockbuster drugs like Keytruda, a leading immuno-oncology treatment…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
